Punch Newspapers·4 min read·hard
Drugmakers' Finance Costs Jump 47% Amid High Interest Rates
A
Arinze Nwafor
✦AI Summary
Nigerian pharmaceutical companies listed on the Nigerian Exchange saw a 46.5% increase in finance costs during Q1 2026 due to high interest rates and increased debt. While some companies managed to grow operating profits, the rising cost of borrowing is putting significant pressure on sector profitability.
Why it matters
This trend highlights the broader economic challenges faced by the Nigerian industrial sector as high interest rates impact corporate growth and financial stability.
Industrial Pharmaceutical Supply Chain. Photo: ASC Software
businesseconomy
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in